Intravitreal injections consist in injecting a special substance directly into the eye’s vitreous body, that is, the clear jelly-like substance inside the eye. Once injected, the substance, an anti-vascular endothelial growth factor such as Avastin or Lucentis, spreads to the retina. The substance is used to prevent the formation of new blood vessels (or neovessels) that tend to leak blood and fluid. Without treatment, these vessels damage the centre of the retina (macula), causing rapid loss of central vision. The injections are used to treat a number of conditions, including wet (or exudative) aged-related macular degeneration (ARMD), advanced diabetic retinopathy (DR), retinal vein occlusions (RVO) and macular edema. This is a lifetime treatment that must be repeated every 4 to 6 weeks in order to stabilize the disease.
Printable booklet for patients
To contact us by phone
Fill in our contact form
Send us your CV : Click here
Exit 23 from highway 15, 4800, Ambroise-Lafortune street, Boisbriand (Quebec) J7H 1S6
Tel. : (450) 419-6345, 1-888-419-6345|Fax. : 450-434-9389|Our coordinates and opening hours
For non-Canadians residents, please contact with us.
© 2011-2017 Institut de l'oeil des Laurentides (IOL)